51.   Strong sales of their blockbuster drugs helped Pfizer Inc. and Bristol-Myers Squibb Co. report solid fourth-quarter earnings.

52.   The results of the first head-to-head studies of two blockbuster arthritis pain drugs -- paid for by the pharmaceutical companies -- produced a split decision on Thursday.

53.   This year, the biggest new blockbuster prescription drug was supposed to be the hypertension medicine Vanlev.

54.   The revenue came from blockbuster drugs such as the ulcer medication Zantac, it said.